Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
warfarin teva tafla 3 mg
teva b.v.* - warfarinum natríum - tafla - 3 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
zinacef stungulyfs-/innrennslisstofn, lausn 1,5 g
sandoz a/s - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 1,5 g
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
zinacef stungulyfs-/innrennslisstofn, lausn 750 mg
sandoz a/s - cefuroximum natríum - stungulyfs-/innrennslisstofn, lausn - 750 mg
Ευρωπαϊκή Ένωση -
Ισλανδικά -
EMA (European Medicines Agency)
thelin
pfizer ltd. - sitaxentan natríum - háþrýstingur, lungnabólga - háþiýstingslækkandi - meðferð sjúklinga með lungnaháþrýsting (pah) flokkuð sem who starfrækslaflokkur iii, til að bæta æfingargetu. verkun hefur verið sýnd við frumháþrýsting og lungnaháþrýsting í tengslum við blóðfrumusjúkdóm.
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
flucloxacillin wh stungulyfs-/innrennslisstofn, lausn 1000 mg
williams & halls ehf.* - flucloxacillinum natríum - stungulyfs-/innrennslisstofn, lausn - 1000 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
kefzol stungulyfs-/innrennslisstofn, lausn 1 g
stada nordic aps. - cefazolinum natríum - stungulyfs-/innrennslisstofn, lausn - 1 g
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
myfortic magasýruþolin tafla 180 mg
novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 180 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
myfortic magasýruþolin tafla 360 mg
novartis healthcare a/s - mycophenolatum natríum - magasýruþolin tafla - 360 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
pariet magasýruþolin tafla 10 mg
eisai ab - rabeprazolum natríum - magasýruþolin tafla - 10 mg
Ισλανδία -
Ισλανδικά -
LYFJASTOFNUN (Icelandic Medicines Agency)
pariet magasýruþolin tafla 20 mg
eisai ab - rabeprazolum natríum - magasýruþolin tafla - 20 mg